By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Second Genome 

1700 Owens Street, 5th Floor

San Francisco  California  94158  U.S.A.
Phone: 888-666-0859 Fax: n/a



Company News
Backed by Pfizer (PFE) and Roche (RHHBY), Bay Area's Second Genome Nabs $42.6 Million 4/20/2016 5:47:25 AM
Second Genome Announces Inflammatory Bowel Disease Research Alliance With The APC Microbiome Institute At University College Cork 4/27/2015 6:58:55 AM
Second Genome And Evotec AG (EVTG.F) To Collaborate In Microbiome Discovery And Development 3/13/2015 8:05:27 AM
Second Genome Advances Lead Microbiome Drug Development Program In Phase I Clinical Trial As A Treatment For Inflammatory Bowel Disease 1/12/2015 8:26:47 AM
Second Genome And Mayo Clinic Enter Collaboration To Develop Microbiome Therapeutics In Multiple Diseases 10/7/2014 9:15:03 AM
Second Genome Appoints Karim Dabbagh, Ph.D., As Chief Scientific Officer 9/9/2014 7:45:46 AM
South San Francisco's Second Genome Strikes Microbiome Pact With Pfizer Inc. (PFE) 5/2/2014 6:41:33 AM
Second Genome Gets Johnson & Johnson (JNJ) Deal, $6.5 Million, to Delve Into Bugs in the Gut 6/5/2013 7:04:23 AM
Second Genome Sponsors American Gut Initiative to Identify Links Between Type 2 Diabetes and the Human Microbiome 1/7/2013 10:23:58 AM
Second Genome Announces $5 Million Series A Financing 8/9/2011 8:04:25 AM